DK0871453T3 - Farmaceutisk kombinationspræparat til hormonal kontraception - Google Patents
Farmaceutisk kombinationspræparat til hormonal kontraceptionInfo
- Publication number
- DK0871453T3 DK0871453T3 DK96913497T DK96913497T DK0871453T3 DK 0871453 T3 DK0871453 T3 DK 0871453T3 DK 96913497 T DK96913497 T DK 96913497T DK 96913497 T DK96913497 T DK 96913497T DK 0871453 T3 DK0871453 T3 DK 0871453T3
- Authority
- DK
- Denmark
- Prior art keywords
- hormone
- pct
- active ingredient
- preparation
- days
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19513662A DE19513662A1 (de) | 1995-04-08 | 1995-04-08 | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
PCT/EP1996/001529 WO1996032114A1 (de) | 1995-04-08 | 1996-04-04 | Pharmazeutisches kombinationspräparat zur hormonalen kontrazeption |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0871453T3 true DK0871453T3 (da) | 2003-09-15 |
Family
ID=7759440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96913497T DK0871453T3 (da) | 1995-04-08 | 1996-04-04 | Farmaceutisk kombinationspræparat til hormonal kontraception |
Country Status (16)
Country | Link |
---|---|
US (1) | US5980940A (ja) |
EP (1) | EP0871453B1 (ja) |
JP (1) | JPH11503440A (ja) |
KR (1) | KR19980703702A (ja) |
CN (1) | CN1077430C (ja) |
AT (1) | ATE240735T1 (ja) |
AU (1) | AU713771B2 (ja) |
CA (1) | CA2217564A1 (ja) |
DE (2) | DE19513662A1 (ja) |
DK (1) | DK0871453T3 (ja) |
ES (1) | ES2200062T3 (ja) |
NO (1) | NO313269B1 (ja) |
NZ (1) | NZ307178A (ja) |
PT (1) | PT871453E (ja) |
RU (1) | RU2165259C2 (ja) |
WO (1) | WO1996032114A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214815B1 (en) * | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
KR100772852B1 (ko) * | 1999-09-23 | 2007-11-02 | 젠타리스 게엠베하 | 자궁내막증 치료용 약제학적 조성물 |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
DE10100911A1 (de) * | 2001-01-11 | 2002-08-01 | Schering Ag | Verfahren zur Hormonersatztherapie und dessen Darreichungsform |
CA2468748C (en) * | 2001-12-05 | 2010-01-26 | Barr Laboratories, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
CN101001631B (zh) * | 2003-07-16 | 2014-08-06 | 特卫华妇女健康有限公司 | 利用连续给予***的避孕方案的激素治疗方法 |
RU2006114791A (ru) * | 2003-10-01 | 2007-11-27 | Янссен Фармацевтика Н.В. (Be) | Продленные режимы трехфазных контрацептивов |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
US20070077269A1 (en) * | 2005-10-04 | 2007-04-05 | Woodward John R | Method of birth control and hormone regulation |
WO2010042610A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc. | Transdermal delivery |
US9198919B2 (en) | 2008-10-08 | 2015-12-01 | Agile Therapeutics, Inc. | Contraceptive transdermal delivery of hormones |
US9198876B2 (en) | 2008-10-08 | 2015-12-01 | Agile Therapeutics, Inc. | Contraceptive transdermal delivery of hormones |
WO2010111488A1 (en) | 2009-03-27 | 2010-09-30 | Agile Therapeutics, Inc. | Transdermal delivery |
EP2880598A4 (en) * | 2012-07-31 | 2016-03-09 | Univ New York | IMPACT-SAFE PROCEDURE ABOUT ATTRIBUTES |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6615481A (ja) * | 1966-11-02 | 1968-05-03 | ||
AU4168068A (en) * | 1969-07-22 | 1971-01-28 | Unisearch Limited | Improvements in or relating to oral contraceptives |
US4921843A (en) * | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
GB8413070D0 (en) * | 1984-05-22 | 1984-06-27 | Mortimer C H | Treatment of hair loss |
US5122382A (en) * | 1990-10-29 | 1992-06-16 | Alza Corporation | Transdermal contraceptive formulations, methods and devices |
DE4104385C1 (ja) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich | |
NL9301562A (nl) * | 1993-09-09 | 1995-04-03 | Saturnus Ag | Preparaat voor substitutietherapie. |
AU7843094A (en) * | 1993-09-23 | 1995-04-10 | Ortho Pharmaceutical Corporation | Methods for the reduction of postmenopausal ldl cholesterol |
DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
DE4344405C2 (de) * | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption |
DE4411585A1 (de) * | 1994-03-30 | 1995-10-05 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
-
1995
- 1995-04-08 DE DE19513662A patent/DE19513662A1/de not_active Ceased
-
1996
- 1996-04-04 DE DE59610462T patent/DE59610462D1/de not_active Expired - Fee Related
- 1996-04-04 CN CN96193156A patent/CN1077430C/zh not_active Expired - Fee Related
- 1996-04-04 CA CA002217564A patent/CA2217564A1/en not_active Abandoned
- 1996-04-04 AT AT96913497T patent/ATE240735T1/de not_active IP Right Cessation
- 1996-04-04 RU RU97118464/14A patent/RU2165259C2/ru not_active IP Right Cessation
- 1996-04-04 DK DK96913497T patent/DK0871453T3/da active
- 1996-04-04 EP EP96913497A patent/EP0871453B1/de not_active Expired - Lifetime
- 1996-04-04 ES ES96913497T patent/ES2200062T3/es not_active Expired - Lifetime
- 1996-04-04 PT PT96913497T patent/PT871453E/pt unknown
- 1996-04-04 KR KR1019970707102A patent/KR19980703702A/ko active IP Right Grant
- 1996-04-04 JP JP8530708A patent/JPH11503440A/ja active Pending
- 1996-04-04 AU AU56462/96A patent/AU713771B2/en not_active Ceased
- 1996-04-04 WO PCT/EP1996/001529 patent/WO1996032114A1/de active IP Right Grant
- 1996-04-04 NZ NZ307178A patent/NZ307178A/xx unknown
- 1996-04-04 US US08/930,630 patent/US5980940A/en not_active Expired - Lifetime
-
1997
- 1997-10-07 NO NO19974630A patent/NO313269B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE19513662A1 (de) | 1996-10-10 |
CN1077430C (zh) | 2002-01-09 |
JPH11503440A (ja) | 1999-03-26 |
US5980940A (en) | 1999-11-09 |
NO974630D0 (no) | 1997-10-07 |
ES2200062T3 (es) | 2004-03-01 |
CN1181011A (zh) | 1998-05-06 |
WO1996032114A1 (de) | 1996-10-17 |
PT871453E (pt) | 2003-10-31 |
NO313269B1 (no) | 2002-09-09 |
KR19980703702A (ko) | 1998-12-05 |
AU5646296A (en) | 1996-10-30 |
EP0871453A1 (de) | 1998-10-21 |
AU713771B2 (en) | 1999-12-09 |
NZ307178A (en) | 2000-01-28 |
DE59610462D1 (de) | 2003-06-26 |
EP0871453B1 (de) | 2003-05-21 |
NO974630L (no) | 1997-12-05 |
ATE240735T1 (de) | 2003-06-15 |
CA2217564A1 (en) | 1996-10-17 |
RU2165259C2 (ru) | 2001-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0750501T3 (da) | Farmaceutisk kombinationspræparat til hormonal kontraception | |
NO976067D0 (no) | Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon | |
US4425339A (en) | Treatment of menopausal symptoms | |
DK0871453T3 (da) | Farmaceutisk kombinationspræparat til hormonal kontraception | |
ES2086644T3 (es) | Preparado anovulatorio para la contracepcion hormonal. | |
KR20070004919A (ko) | 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리 | |
JP4908399B2 (ja) | 天然エストロゲンに基づく段階型避妊製剤 | |
Benagiano et al. | Seventy‐five microgram desogestrel minipill, a new perspective in estrogen‐free contraception | |
WO1994002103A3 (de) | Ovulationshemmendes mittel zur hormonalen kontrazeption | |
CA2248841A1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |